Answer
It is licensed for adults with late-onset Pompe disease; safety and efficacy below age 18 have not been established.
Sources for this answer
- Pombiliti 105 mg powder for concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.